熱點掃描 | 芯片股全線大漲，多家芯片企業業績亮眼
uSMART盈立智投6月30日消息，截止發稿，恆指轉跌，跌0.12%，報28960.41，成交額550.11億，國企指數跌0.26%，恆生科技指數漲0.20%，港股通淨流入7.45億。
芯片股漲幅居前，截止10:59，節能元件、晶門半導體均漲超11%，上海復旦漲超8%，華虹半導體漲超3%，中芯國際漲超2%。消息面上，多家半導體芯片企業發佈半年報業績預告，業績表現亮眼。截至目前，已有近20只半導體概念股披露2021年業績預計情況，其中13只個股錄得預增。
博彩板塊“6連跌”後迎來反彈，截止10:59，澳博控股漲超5%，銀河娛樂、金沙中國漲超4%，永利澳門漲超3%，新濠國際漲超2%，美高梅中國漲超1%。消息面上，澳門旅遊局局長文綺華表示，對暑假訪澳旅客數字回覆保持樂觀，相信可以回覆至4、5月水平。她指出，預料今年全年有約700萬至800萬人次訪澳。
航運股走強，截止10:59，海豐國際漲近4%，中遠海控、東方海外國際漲超3%，此前，振華重工宣佈減持中遠海控不超過5561.11萬股票，北向資金也連續兩日淨流出該股；中國外運、中遠海發、太平洋航運漲超1%。
恆科成分股方面，截止10:59，網易、京東、百度、同程藝龍、金蝶國際均漲超1%，阿裏漲幅不足1%，騰訊股價幾乎持平；閱文跌2%，快手、b站、美團、小米均跌超1%。
汽車板塊走弱，截止10:59，吉利汽車、長城汽車跌超3%，吉利汽車早前公佈撤回上海科創板上市申請；比亞迪股份、五菱汽車跌超1%，恆大汽車則漲超2%。
生物醫藥股普遍走低，截止10:59，藥明巨諾跌超4%，日前，藥明巨諾遭股東藥明康德減持約6.55億港元；金斯瑞生物科技跌超4%，中國抗體、華領醫藥跌超3%，嘉和生物跌超2%，科濟藥業跌超2%，百濟神州、君實生物跌超1%。
個股方面，截止10:59，奈雪的茶首日上市破發，現跌超10%，報17.74元；現代牧業漲超13%，大和預計上半年純利將提升1.25倍，維持“買入”評級；心動公司漲超13%，獲主席黃一孟增持涉資約6448.7萬港元；洛陽玻璃漲超11%領漲光伏股，光伏產業鏈價格開始鬆動，硅料年內首次降價。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
